J Maeda, N Ueki, T Hada and K Higashino
Third Department of Internal Medicine, Hyogo College of Medicine, Japan.

Hepatocyte growth factor/scatter factor (HGF/SF) plays an important role in tissue repair in liver and renal damage. The clinical significance of this growth factor in these diseases has also been reported. The lung is one of the major sources of HGF/SF; because of this, we investigated serum HGF/SF levels in 26 patients with inflammatory lung disease (15 with interstitial pneumonitis [IP], 11 with bacterial pneumonia [BP]) by enzyme-linked immunosorbent assay. As controls, we measured HGF/SF in the serum of 13 stable outpatients with chronic respiratory failure. All patients had no significant liver or renal dysfunction. Serum HGF/SF levels were significantly elevated in patients with IP (1.16 +/- 0.22 ng/ml) or BP (0.96 +/- 0.27 ng/ml) compared with those in the control subjects (0.29 +/- 0.03 ng/ml, both p < 0.01). Serum HGF/SF levels in 14 healthy subjects were also studied, and the results (0.30 +/- 0.02 ng/ml) were not remarkably different from those of the control subjects. There were no significant correlations between serum HGF/SF levels and C-reactive protein and lactate dehydrogenase. Serum HGF/SF levels in the surviving patients rapidly decreased with treatment, but they did not change in the patients who ultimately died. Our results demonstrate the clinical significance of serum HGF/SF level as a useful indicator of prognosis in inflammatory lung disease.

This article has been cited by other articles:

				M. Cohen, S. Marchand-Adam, V. Lecon-Malas, J. Marchal-Somme, A. Boutten, G. Durand, B. Crestani, and M. Dehoux HGF synthesis in human lung fibroblasts is regulated by oncostatin M Am J Physiol Lung Cell Mol Physiol, June 1, 2006; 290(6): L1097 - L1103. [Abstract] [Full Text] [PDF]

				R. Fend, R. Geddes, S. Lesellier, H.-M. Vordermeier, L. A. L. Corner, E. Gormley, E. Costello, R. G. Hewinson, D. J. Marlin, A. C. Woodman, et al. Use of an Electronic Nose To Diagnose Mycobacterium bovis Infection in Badgers and Cattle J. Clin. Microbiol., April 1, 2005; 43(4): 1745 - 1751. [Abstract] [Full Text] [PDF]

				R. M. Day, G. Thiel, J. Lum, R. D. Chevere, Y. Yang, J. Stevens, L. Sibert, and B. L. Fanburg Hepatocyte Growth Factor Regulates Angiotensin Converting Enzyme Expression J. Biol. Chem., March 5, 2004; 279(10): 8792 - 8801. [Abstract] [Full Text] [PDF]

				L. B. Ware and M. A. Matthay Keratinocyte and hepatocyte growth factors in the lung: roles in lung development, inflammation, and repair Am J Physiol Lung Cell Mol Physiol, May 1, 2002; 282(5): L924 - L940. [Abstract] [Full Text] [PDF]

				T. YAMADA, M. HISANAGA, Y. NAKAJIMA, S. MIZUNO, K. MATSUMOTO, T. NAKAMURA, and H. NAKANO Enhanced Expression of Hepatocyte Growth Factor by Pulmonary Ischemia-Reperfusion Injury in the Rat Am. J. Respir. Crit. Care Med., August 1, 2000; 162(2): 707 - 715. [Abstract] [Full Text] [PDF]

				T. Nagahori, M. Dohi, K. Matsumoto, K. Saitoh, Z.-I. Honda, T. Nakamura, and K. Yamamoto Interferon-gamma Upregulates the c-Met/Hepatocyte Growth Factor Receptor Expression in Alveolar Epithelial Cells Am. J. Respir. Cell Mol. Biol., October 1, 1999; 21(4): 490 - 497. [Abstract] [Full Text]

				G. M. VERGHESE, K. MCCORMICK-SHANNON, R. J. MASON, and M. A. MATTHAY Hepatocyte Growth Factor and Keratinocyte Growth Factor in the Pulmonary Edema Fluid of Patients with Acute Lung Injury . Biologic and Clinical Significance Am. J. Respir. Crit. Care Med., August 1, 1998; 158(2): 386 - 394. [Abstract] [Full Text] [PDF]

				M Yaekashiwa, S Nakayama, K Ohnuma, T Sakai, T Abe, K Satoh, K Matsumoto, T Nakamura, T Takahashi, and T Nukiwa Simultaneous or delayed administration of hepatocyte growth factor equally represses the fibrotic changes in murine lung injury induced by bleomycin. A morphologic study Am. J. Respir. Crit. Care Med., December 1, 1997; 156(6): 1937 - 1944. [Abstract] [Full Text]